Comorbid conditions are very common in elderly cardiovascular patients. Therefore, the management of comorbid patients has become an important health problem with the increasing elderly population. There are currently no recommendations in the treatment guidelines that are specific enough for comorbid conditions. In order to improve this patients quality of life holistic approach, good evaluation of risk-benefit ratio and possible drug interactions should be considered carefully.